Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05005949 · ClinicalTrials.gov registry record
STOP Persistent AF PAS
A clinical trial of Persistent Atrial Fibrillation, sponsored by Medtronic Cardiac Ablation Solutions.
- Active
- Registry status
- 400
- Enrollment target
- 17
- Study locations
NCT05005949: Active study of Persistent Atrial Fibrillation, sponsored by Medtronic Cardiac Ablation Solutions.
NCT05005949 is a study of Persistent Atrial Fibrillation that is active but no longer recruiting, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 400 participants, below the 1,234-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (68% lower). The trial reports 17 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05005949, a study of Persistent Atrial Fibrillation, is active but no longer recruiting, sponsored by Medtronic Cardiac Ablation Solutions.
- ACTIVE NOT RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 17
- Study locations
Study Summary
The STOP Persistent AF Post Approval Study (PAS) is a prospective, global, multicenter, observational trial.
Primary Outcome
Estimate the 36-month freedom from Atrial Fibrillation (AF) /Atrial Flutter (AFL) /Atrial Tachycardia (AT) recurrence using the Arctic Front™ Cardiac Cryoablation Catheter System.
Conditions Studied
Interventions
- DEVICE Arctic Front™ Cardiac Cryoablation Catheter System
Study Locations (17)
Other
- Kepler Universitätsklinikum Med Campus III. - Linz
- St. Vinzenz-Hospital Köln - Cologne
- MVZ CCB Frankfurt und Main Taunus - Frankfurt am Main
- Städtische Kliniken München GmbH - Klinikum Bogenhausen - München
- Universitaria Pisana - Stabilimento di Cisanello - Pisa
- Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodz - Lodz
- Liverpool Heart and Chest Hospital NHS Foundation Trust - Liverpool
Connecticut
- Hartford Hospital - Hartford
- Cardiology Associates of Fairfield County - Stamford
Florida
- BayCare Medical Group Cardiology - Clearwater
- Heart Rhythms Solutions - Davie
Michigan
- Henry Ford Heart & Vascular - Detroit
- Spectrum Health Hospitals - Grand Rapids
Texas
- Texas Cardiac Arrhythmia Research Foundation - Austin
- Texas Health Research & Education Institute - Dallas
Illinois
- Carle Foundation Hospital - Urbana
Ohio
- The Lindner Research Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2021-08-19 |
| Est. Completion | 2028-07 |
What the registry record for NCT05005949 still lists
NCT05005949 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,234-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Arctic Front™ Cardiac Cryoablation Catheter System is the first listed.
NCT05005949 lists 17 locations in 7 states (Other, Connecticut, Florida).
Frequently Asked Questions
What is clinical trial NCT05005949 about?
NCT05005949 is a clinical study titled "STOP Persistent AF PAS". The STOP Persistent AF Post Approval Study (PAS) is a prospective, global, multicenter, observational trial.
What is the current status of trial NCT05005949?
This trial is currently active not recruiting. The enrollment target is 400 participants. The study started on 2021-08-19. Estimated completion is 2028-07.
What conditions does trial NCT05005949 study?
This clinical trial studies the following conditions: Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT05005949?
The interventions under investigation include: Arctic Front™ Cardiac Cryoablation Catheter System (DEVICE).
Who is sponsoring clinical trial NCT05005949?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05005949 being conducted?
This trial has 17 study locations across Connecticut, Florida, Illinois, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05005949's enrollment target sits among peer trials
400 5th of 15 higher than 11 of 15 other Persistent Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Persistent Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endocardial Mapping With the CoreMap EP Mapping System
RECRUITING · NA
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
ARIADNE Clinical Trial
RECRUITING · NA
-
SPHERE Per-AF Post-Approval Study
RECRUITING
-
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
RECRUITING · Phase 4
-
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI